Black Diamond Therapeutics, Inc.

{
  "main_header": {
    "sid": 1240570,
    "name": "Black Diamond Therapeutics, Inc.",
    "stock_name": "Black Diamond Therapeutics, Inc.",
    "full_name": "Black Diamond Therapeutics, Inc.",
    "name_url": "stocks-analysis/black-diamond-therapeutics-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "2.16",
    "chg": -0.36,
    "chgp": "-14.29%",
    "dir": -1,
    "prev_price": "2.52",
    "mcapval": "146.43",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US09203E1055",
    "curr_date": "Feb 05",
    "curr_time": "",
    "bse_nse_vol": "1.42 M",
    "exc_status": "Active",
    "traded_date": "Feb 05, 2026",
    "traded_date_str": "2026 02 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/black-diamond-therapeutics-inc-1240570-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Black Diamond Therapeutics, Inc. Experiences Valuation Adjustment Amidst Competitive Market Landscape",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/black-diamond-therapeutics-changes-valuation-grade-from-attractive-to-very-attractive-3686316",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/BlackDiamondThe_valuationdot_3686316.png",
        "date": "2025-11-10 16:11:53",
        "description": "Black Diamond Therapeutics, Inc. has recently adjusted its valuation, showcasing a P/E ratio of 29 and a low PEG ratio of 0.27, indicating potential growth. The company demonstrates strong operational efficiency with a ROCE of 55.79%. Year-to-date, it has significantly outperformed the S&P 500, despite long-term challenges."
      }
    ],
    "total": 15,
    "sid": "1240570",
    "stock_news_url": "https://www.marketsmojo.com/news/black-diamond-therapeutics-inc-1240570"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Black Diamond Therapeutics, Inc. Experiences Valuation Adjustment Amidst Competitive Market Landscape

2025-11-10 16:11:53

Black Diamond Therapeutics, Inc. has recently adjusted its valuation, showcasing a P/E ratio of 29 and a low PEG ratio of 0.27, indicating potential growth. The company demonstrates strong operational efficiency with a ROCE of 55.79%. Year-to-date, it has significantly outperformed the S&P 500, despite long-term challenges.

Read full news article

View All News